TCF7L2 and atherosclerosis: TCF7L2 is a downstream transcription factor in the canonical Wnt/β-catenin pathway, and it has been shown to be involved in insulin synthesis, vascular cell proliferation, inflammation, and plaque formation, all of which are key processes in atherosclerosis 39,58.